AYGEN, B. Et Al. 2017. Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4. J Immunol Clin Microbiol , vol.2, no.1 , 1.

AYGEN, B., YILDIZ, O., GÖKAHMETOĞLU, S., TAHERİ, S., & TÜRE, Z., (2017). Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4. J Immunol Clin Microbiol , vol.2, no.1, 1.

AYGEN, BİLGEHAN Et Al. "Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4," J Immunol Clin Microbiol , vol.2, no.1, 1, 2017

AYGEN, BİLGEHAN Et Al. "Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4." J Immunol Clin Microbiol , vol.2, no.1, pp.1, 2017

AYGEN, B. Et Al. (2017) . "Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4." J Immunol Clin Microbiol , vol.2, no.1, p.1.

@article{article, author={BİLGEHAN AYGEN Et Al. }, title={Telaprevir combination therapy in patients infected with hepatitis C virus genotype 4}, journal={J Immunol Clin Microbiol}, year=2017, pages={1} }